XML 89 R61.htm IDEA: XBRL DOCUMENT v3.19.3
Reportable Segments and Major Concentration Data - Segment Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2017
Segment Reporting Information [Line Items]                      
Net revenues $ 50,846 $ 48,440 $ 50,248 $ 51,480 $ 53,100 $ 51,737 $ 56,451 $ 52,283 $ 201,014 $ 213,571 $ 200,771
Operating income                 32,699 31,584 37,382
Depreciation and amortization                 9,964 8,688 9,090
Capital expenditures                 3,797 4,201 4,467
Goodwill 89,241       54,637       89,241 54,637 54,926
Other intangible assets 60,243       23,113       60,243 23,113 26,704
Total assets 325,478       251,377       325,478 251,377 249,777
Restructuring and litigation costs                 2,596 7,779 762
Diagnostics [Member]                      
Segment Reporting Information [Line Items]                      
Net revenues                 136,682 150,454 143,521
Life Science [Member]                      
Segment Reporting Information [Line Items]                      
Net revenues                 64,332 63,117 57,250
Corporate [Member]                      
Segment Reporting Information [Line Items]                      
Operating income                 (10,373) (15,076) (11,097)
Eliminations [Member]                      
Segment Reporting Information [Line Items]                      
Operating income                 101 292 269
Total assets (83)       58       (83) 58  
Net revenues                 (823) (789) (926)
Operating Segments [Member] | Diagnostics [Member]                      
Segment Reporting Information [Line Items]                      
Net revenues                 136,682 150,454 143,521
Operating income                 22,399 32,569 34,124
Depreciation and amortization                 7,676 6,557 7,037
Capital expenditures                 2,049 2,477 2,554
Goodwill 70,395       35,213       70,395 35,213 35,213
Other intangible assets 59,807       22,068       59,807 22,068 24,973
Total assets 255,169       180,978       255,169 180,978 180,226
Net revenues                 462 392 389
Operating Segments [Member] | Life Science [Member]                      
Segment Reporting Information [Line Items]                      
Net revenues                 64,332 63,117 57,250
Operating income                 20,572 13,799 14,086
Depreciation and amortization                 2,288 2,131 2,053
Capital expenditures                 1,748 1,724 1,913
Goodwill 18,846       19,424       18,846 19,424 19,713
Other intangible assets 436       1,045       436 1,045 1,731
Total assets $ 70,392       $ 70,341       70,392 70,341 69,938
Net revenues                 $ 361 $ 397 537
Operating Segments [Member] | Eliminations [Member]                      
Segment Reporting Information [Line Items]                      
Total assets                     $ (387)